These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

53 related articles for article (PubMed ID: 3912847)

  • 1. Proposal to remove an E. coli host-vector system producing a hybrid toxin from BL4 containment.
    Recomb DNA Tech Bull; 1985 Dec; 8(4):195-6. PubMed ID: 3912847
    [No Abstract]   [Full Text] [Related]  

  • 2. [Design and expression of the gene for diphtheria toxin-streptavidin hybrid protein in Escherichia coli].
    Shemiakin IG; Anisimova VA; Kopylov PKh; Pozmogova GE; Chuvilin AN; Manzeniuk OIu; Los' TA; Shcherbakov GIa
    Mol Biol (Mosk); 1997; 31(5):790-4. PubMed ID: 9454061
    [No Abstract]   [Full Text] [Related]  

  • 3. Diphtheria toxin expression in Escherichia coli.
    Greenfield L
    Targeted Diagn Ther; 1992; 7():307-38. PubMed ID: 1633297
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetic construction, expression, and melanoma-selective cytotoxicity of a diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion protein.
    Murphy JR; Bishai W; Borowski M; Miyanohara A; Boyd J; Nagle S
    Proc Natl Acad Sci U S A; 1986 Nov; 83(21):8258-62. PubMed ID: 3095831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Request to clone a hybrid toxin gene in E. coli K-12.
    Recomb DNA Tech Bull; 1985 Dec; 8(4):191-3. PubMed ID: 3938033
    [No Abstract]   [Full Text] [Related]  

  • 6. Proposal to clone Shiga-like toxin gene from E. coli.
    Recomb DNA Tech Bull; 1984 Sep; 7(3):130-41. PubMed ID: 6393228
    [No Abstract]   [Full Text] [Related]  

  • 7. Request for permission to lower containment conditions for the cloning of the gene for Shiga-like toxin from E. coli.
    Recomb DNA Tech Bull; 1984 Mar; 7(1):34. PubMed ID: 6374770
    [No Abstract]   [Full Text] [Related]  

  • 8. Request for permission to lower containment conditions for the cloning of the gene for Shiga-like toxin from E. coli.
    Recomb DNA Tech Bull; 1984 Jun; 7(2):80-3. PubMed ID: 6382451
    [No Abstract]   [Full Text] [Related]  

  • 9. Bacterial toxins: a table of lethal amounts.
    Gill DM
    Microbiol Rev; 1982 Mar; 46(1):86-94. PubMed ID: 6806598
    [No Abstract]   [Full Text] [Related]  

  • 10. Diphtheria toxin-related alpha-melanocyte-stimulating hormone fusion toxin. Internal in-frame deletion from Thr387 to His485 results in the formation of a highly potent fusion toxin which is resistant to proteolytic degradation.
    Wen ZL; Tao X; Lakkis F; Kiyokawa T; Murphy JR
    J Biol Chem; 1991 Jul; 266(19):12289-93. PubMed ID: 1648090
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Construction and expression of the fusion protein DT389-hIL-13 and its cytotoxicity to glioma cell lines].
    Tuo HZ; Wang JW; Wang DX; Li JM; Ouyang J; Hong T
    Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(12):1024-8. PubMed ID: 15312540
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of a mutant, full-length form of diphtheria toxin in Escherichia coli.
    Barbieri JT; Collier RJ
    Infect Immun; 1987 Jul; 55(7):1647-51. PubMed ID: 3110068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-level expression and purification of the recombinant diphtheria fusion toxin DTGM for PHASE I clinical trials.
    Frankel AE; Ramage J; Latimer A; Feely T; Delatte S; Hall P; Tagge E; Kreitman R; Willingham M
    Protein Expr Purif; 1999 Jun; 16(1):190-201. PubMed ID: 10336877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression and purification of immunologically reactive DPPD, a recombinant Mycobacterium tuberculosis skin test antigen, using Mycobacterium smegmatis and Escherichia coli host cells.
    Liu C; Flamoe E; Chen HJ; Carter D; Reed SG; Campos-Neto A
    Can J Microbiol; 2004 Feb; 50(2):97-105. PubMed ID: 15052311
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Production of recombinant DTctGMCSF fusion toxin in a baculovirus expression vector system for biotherapy of GMCSF-receptor positive hematologic malignancies.
    Williams MD; Rostovtsev A; Narla RK; Uckun FM
    Protein Expr Purif; 1998 Jul; 13(2):210-21. PubMed ID: 9675065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetic construction, expression, and characterization of diphtheria toxin-based growth factor fusion proteins.
    vanderSpek JC; Murphy JR
    Methods Mol Biol; 2000; 145():89-99. PubMed ID: 10820717
    [No Abstract]   [Full Text] [Related]  

  • 17. Reconstitution of active diphtheria toxin based on a hexahistidine tagged version of the B-fragment produced to high yields in bacteria.
    Spilsberg B; Sandvig K; Wälchli S
    Toxicon; 2005 Dec; 46(8):900-6. PubMed ID: 16260019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Targeted intracellular site-specific drug delivery: photosensitizer targeting to melanoma cell nuclei].
    Rozenkrants AA; Lunin VG; Sergienko OV; Giliazova DG; Voronina OL; Ians DE; Kofner AA; Shumiantseva MA; Mironov AF; Sobolev AS
    Genetika; 2003 Feb; 39(2):259-68. PubMed ID: 12669423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virulence profiles of Shiga toxin 2e-producing Escherichia coli isolated from healthy pig at slaughter.
    Zweifel C; Schumacher S; Beutin L; Blanco J; Stephan R
    Vet Microbiol; 2006 Oct; 117(2-4):328-32. PubMed ID: 16872761
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Factors affecting ability of experimental vaccines to protect guinea pigs against lethal challenge with diphtheria toxin.
    Maleckar JR; Fossceco S; Katkocin D
    Biologicals; 1999 Jun; 27(2):185. PubMed ID: 10600211
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.